Investigation of time course of changes in the concentrations of angiogenic factors on the length of physiological pregnancy
- Authors: Yakovleva N.Y.1, Vasilyeva E.Y.1, Shelepova E.S1, Ryabokon N.R1, Khazova E.L1, Buravleva K.R2, Kuznetsova L.V3, Zazerskaya I.E3
-
Affiliations:
- V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
- Obstetrics and Gynecology
- V.A. Almazov North-West Federal Medical Research Center
- Issue: No 8 (2016)
- Pages: 49-53
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247742
- DOI: https://doi.org/10.18565/aig.2016.8.49-53
- ID: 247742
Cite item
Abstract
Full Text
About the authors
N. Yu Yakovleva
V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
Email: Natalis.1986@mail.ru
MD, researcher of scientific research laboratory of physiology and pathology of pregnancy and delivery
E. Yu Vasilyeva
V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
Email: elena-almazlab@yandex.ru
MD, head of central diagnostic laboratory
E. S Shelepova
V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
Email: garbunchik@mail.ru
MD, researcher of scientific research laboratory of reproduction and women health
N. R Ryabokon
V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
Email: n-i-k-o-n@mail.ru
MD, Teaching Assistant, chair of Obstetrics and Gynecology
E. L Khazova
V.A. Almazov North-West Federal Medical Research Center, Ministry of Health of Russia
Email: kamishi77@mail.ru
MD, researcher of scientific research laboratory of reproduction and women health
K. R Buravleva
Obstetrics and Gynecology
Email: k_senia9l@mail.ru
resident of chair
L. V Kuznetsova
V.A. Almazov North-West Federal Medical Research Center
Email: krivo73@mail.ru
MD, PhD, assistant professor of chair of Obstetrics and Gynecology
I. E Zazerskaya
V.A. Almazov North-West Federal Medical Research Center
Email: zazera@mail.ru
MD, PhD, head of chair of Obstetrics and Gynecology
References
- Соколов Д.И. Васкулогенез и ангиогенез в развитии плаценты. Журнал акушерства и женских болезней. 2007; 56(3): 129-33. [Sokolov D.I. Angiogenesis and vasculogenesis in development of the placenta. Journal akusherstva i jenskih boleznei/Journal of Obstetrics and gynecological diseases. 2007; 56 (3): 129-133. (in Russian)]
- Ходжаева З.С., Мусиенко Е.В., Сухих Г.Т. Особенности секреции про- и антиангиогенных факторов в I триместре беременности у женщин с привычным выкидышем в анамнезе. Проблемы репродукции. 2011; 2: 30-4. [Khodzaeva Z.S., Musienko E.V., Sukhikh G.T. Features secretion of pro- and anti-angiogenic factors in the I trimester of pregnancy in women with recurrent miscarriage history. Problemi reprodukcii/Problems of reproduction. 2011; 2: 30-34. (in Russian)]
- Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis. Molecular regulation. Placenta. 2004; 25(2-3): 103-13.
- Бурлев В.А., Ильясова Н.А., Саркисов С.Э. Содержание ангиогенных факторов в крови у больных с эндометриальной гиперплазией. Проблемы репродукции. 2011; 6: 18-25. [Burlev V.A., Ilyasov N.A., Sarkisov S.E. Angiogenic factors content in the blood of patients with endometrial hyperplasia. Problemi reprodukcii/Problems of reproduction. 2011; 6: 18-25. (in Russian)]
- Andraweera P.H., Dekker. G.A., Roberts C.T. The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum. Reprod. Update. 2012; 18(4): 436-57.
- Никитина Л.А., Демидова Е.И., Радзинский В.Е., Демидов Б.С., Самоходская Л.М. Роль матриксных белков, цитокинов и факторов ангиогенеза маточно-плацентарного комплекса в регуляции имплантации и плацентации. Акушерство и гинекология. 2007; 3: 5-10. [Nikitina L.A., Demidova E.I., Radzinsky V.E., Demidov B.S., Samokhodskaya L.M. Role of matrix proteins, cytokines and angiogenic factors uteroplacental complex regulation of implantation and placentation. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2007; (3): 5-10. (in Russian)]
- Clark D.E., Smith S.K., He Y., Day K.A., Licence D.R., Corps A.N. et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol. Reprod. 1998; 59(6): 1540-8.
- Koch S., Tugues S., Li X., Ponten A., Thoren P. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011; 437(2): 169-83.
- Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004; 350(7): 672-83.
- Verlohren S., Herraiz I., Lapair O., Schlembach D., Zeisler H., Calda P. et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014; 63(2): 346-52.
- Palm М., Basu S., Larsson A., Wernroth L., A'Kerud H., Akelsson O. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet. Gynecol. Scand. 2011; 90(11): 1244-51.
- Сидорова И.С., Никитина Н.А. Особенности патогенеза эндотелиоза при преэклампсии. Акушерство и гинекология. 2015; 1: 72-8. [Sidorova I.S., Nikitina N.A. Pathogenesis of endotheliosis in preeclampsia. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2015; (1): 72-8. (in Russian)]
- Зиганшина М.М., Кречетова Л.В., Ванько Л.В., Ходжаева З.С., Мусиенко Е.В., Сухих Г.Т. Про- и антиангиогенные факторы в патогенезе ранних потерь беременности. Часть 1. Особенности содержания про- и антиангиогенных сывороточных факторов в ранние сроки беременности. Акушерство и гинекология. 2012; 3: 14-9. [Ziganshina M.M., Krechetova L. V., Vanko L. V., Khodzhayeva Z.S., Musiyenko E.V., Sukhikh G.T. Pro- and antiangiogenic factors in the pathogenesis of early pregnancy losses. Part 1.The specific features of pro- and antiangiogenic serum factors in early pregnancy. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2012; (3): 14-9. (in Russian)]
- Johnson P.M., Christmas S.E., Vince G.S. Immunological aspects of implantation and implantation failure. Hum. Reprod. 1999; 14(Suppl.2): 26-36.
- Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983; 219(4587): 983-5.
- Ziche M., Maglione D., Ribatti D., Morbidelli L. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab. Invest. 1997; 76(4): 517-31.
- Yonekura H., Sakurai S., Liu X., Migita H., Wang H., Yamagishi S. et al. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J. Biol. Chem. 1999; 274(49): 35172-8.
- Wikstrom A.K., Larsson A., Eriksson U.J., Nash P., Norden-Lindeberg S., Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet. Gynecol. 2007; 109(6): 1368-74.
- Taylor R.N., Grimwood J., Taylor R.S., McMaster M.T., Fisher S.J., North R.A. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol. 2003; 188(1): 177-82.
- Schiettecatte J., Russcher H., Anckaert E., Mees M., Leeser B., Tirelli A.S. et al. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin. Biochem. 2010; 43(9): 768-70.